INTRODUCTION
Maroteaux-Lamy syndrome (MPS VI) is an autosomal recessive disorder ofmucopolysaccharide catabolism that in its severe form results in dwarfism, gross skeletal changes and cloudy corneas without mental deterioration (McKusick & Neufeld, 1983) . The variability of MPS VI clinical phenotypes (mild to severe) causes considerable difficulty in its clinical recognition and diagnosis. The basis of this heterogeneity of clinical phenotype is unknown, but, as suggested for other mucopolysaccharidoses, may result from different allelic mutations. The known enzyme deficiency responsible for both severe and mild forms of MPS VI is the lysosomal enzyme 4-sulpho-N-acetylgalactosamine sulphatase [first termed arylsulphatase B (aryl B) before the natural substrate in vivo was discovered]. This enzyme is involved in the degradation of dermatan sulphate and chondroitin 4-sulphate. MPS VI patients therefore store and excrete excessive amounts of dermatan sulphate and chondroitin 4-sulphate. We have reported that, compared with the normal, urine from MPS VI patients contains increased (> 450-fold) amounts of the monosaccharides Nacetylgalactosamine 4-sulphate (GalNAc4S) and Nacetylgalactosamine 4,6-disulphate (Hopwood & Elliott, 1985) . These observations suggest that 4-sulphated N-acetylgalactosamines are also substrates in vivo for human aryl B.
The exact diagnosis of MPS VI is based on the demonstration of a gross deficiency of aryl B in, for example, the patient's cultured skin fibroblasts or leucocytes. The importance of the correct diagnosis lies in the hereditary nature of these disorders, and their early recognition allows appropriate family counselling and prenatal diagnosis. The most favoured procedures for assay of aryl B activity utilize one of two readily available synthetic substrates (nitrocatechol sulphate or 4-methylumbelliferyl sulphate) by using either a combination of inhibitors of other arylsulphatase (mainly type A) activities that also desulphate these substrates (Baum et al., 1959) or fractionation of the various arylsulphatase activities by ion-exchange chromatography or electrophoresis (Ratazzi et al., 1973; Fluharty et al., 1974; Schwartz et al., 1980; .
There are now several described variations of other lysosomal enzyme deficiencies in which enzyme activity against commonly used substrates (such as 4-methylumbelliferyl derivatives) does not correspond to activity against substrates that closely conform to substrates in vivo, and errors in diagnosis have thereby arisen (Tallman et al., 1974; Owada et al., 1977; O'Brien et al., 1977) . For the greatest reliability it is therefore important (as in prenatal diagnosis) to use substrates that match as closely as possible the structures of the substrates in vivo. We have previously shown that the structure of the residue adjacent to the group under enzymic attack plays an Abbreviations used: GalNAc4S, N-acetylgalactosamine 4- [(5Sjsulphate; GalitolNAc4S, galactosaminitol 4-sulphate; GalNAc6S, (Hopwood & Muller, 1979 Muller & Hopwood, 1984; Clements et al., 1985; Freeman & Hopwood, 1986) . The detection and assessment of residual mutant enzyme activity in many mucopolysaccharidoses is likely to be successful if the diagnostic substrates match the structure of the substrates used in vivo (Hopwood & Muller, 1979; Muller & Hopwood, 1984) .
Oligosaccharides prepared from chondroitin 4-sulphate have been used to assay specifically aryl B activity in cultured skin fibroblasts (Matalon et al., 1974; Habuchi et al., 1979; Fluharty, 1981; Hopwood & Elliott, 1985 Tsuji et al. (1970) . Radiolabelled N-acetylgalactosaminitol 4-sulphate, GalNAc4S-GlcA-GalitolNAc4S, GalNAc4S-Glc-GalitolNAc4S (Fig. 1 ) and GalNAc6S were prepared as previously described (Hopwood & Elliott, 1983 Elliott & Hopwood, 1984) . GalNAc4S-GlcA-GalNAc4S-GlcA-GalitolNAc4S was prepared by /J-glucuronidase digestion of the hexasaccharide fraction produced in the same preparation used to yield GalNAc4S-GlcA-GalitolNAc4S from the tetrasaccharide (Hopwood & Elliott, 1983 . The pentasaccharide was subjected to the same preparative descending paper chromatography and high-voltage electrophoresis as described for the trisaccharide above. Particular care was taken with the descending-chromatography step described below, which was included to separate GalNAc4S and GalNAc6S trisaccharide species. The single peak of radioactivity obtained in this step was cut into eight segments and the radiolabelled material eluted from each was evaluated as substrates in standard (see 'Enzyme assays' below) incubations containing homogenates of MPS VI fibroblasts. Fractions with very low (less than 0.1 pmol/min per mg of cell protein) activity were pooled and used as a substrate for the specific assessment of aryl B activity. It was not possible to lower aryl B activity assessed with the pentasaccharide substrate to below 1 pmol/min per mg of cell protein with homogenates of MPS VI fibroblasts.
GalNAc4S-Ido ( Fig. 1 ) was prepared from dermaton sulphate (Hopwood & Muller, 1983) . Carboxy reduction of dermatan sulphate (10 mg) was performed by mixing with 30 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodi-imide hydrochloride in 1.7 ml of water at 25°C maintained at pH 4.75 with 0.1 M-HCI by a Radiometer Tritrator II. The reaction consumed approx. 0.2 ml of 0.1 M-HCI during 45 min; the end point was indicated by no further consumption ofacid. The reaction mixture was dialysed at 4°C against two changes of water (2 litres) over a 3 h period and rotary-evaporated to dryness at 30°C, and the total volume was adjusted to 0.1 ml with water. NaBH4 (7 mg) and 100 mCi of NaB3H4 (9.8 Ci/mmol) were added, and the mixture was heated at 50°C for 90 min, cooled to 25°C and acidified with acetic acid in a fume-hood to release tritium gas. The reaction mixture was dialysed successively against four changes ofwater (2 litres) and three changes of0.2 M-NaCl over 3 days at 4°C, then applied to a column (1 cm x 100 cm) of Sephadex G-10, and eluted with 10% (v/v) ethanol at 25 'C. As we have reported for similarly treated heparin, the uronic acid-containing fractions and radiolabelled material, all of which was eluted in the void volume, were combined and freeze-dried, and the residue hydrolysed with 0.1 M-HCI at 100 'C for 1 h (Hopwood & Elliott, 1981a) . The hydrolysate was neutralized with 1 M-NaOH, applied to a column (1 cm x 200 cm) of
Scheme 1. Proposed pathways for exo-degradation of 6Iinked 4-sulphated N-acetylgalactosamine residues of the trisaccharide substrate GaINAc4S-GlcA-GalitolNAc4S derived from chondroitin 4-sulphate Sephadex G-25 and eluted with 0.2 M-NaCl in 0.05 Msodium acetate buffer, pH 5.3, as previously described (Hopwood & Elliott, 1981a) . Radiolabelled material eluted in the same position as a disaccharide standard (iduronosylanhydromannitol 6-sulphate; Muller & Hopwood, 1984) was freeze-dried, dissolved in water (100 pl) and subjected to preparative high-voltage electrophoresis at pH 1.7 (Hopwood & Elliott, 1983) . A single peak of radioactive material was present, with the same mobility as iduronosylanhydromannitol 6-sulphate. The extremely acid-labile 2-O-sulpho-L-idopyranosidic bonds (Shively & Conrad, 1976; Hopwood & Elliott, 1981a) , compared with the relative stability of other glycosidic bonds, dictates the production of disaccharides from the repeating sequence of 2-O-sulpho-L-idopyranosyl-disaccharide in carboxy-group-reduced dermatan sulphate. It is likely that the 2-0-sulphate ester is also hydrolysed under these conditions to yield a mixture of GalNAc4S-idose and GalNAc4S-(1 -* 6)anhydroidose disaccharides. We have not attempted to identify the relative proportions of these two components in the disaccharide fraction, and have tentatively labelled this disaccharide fraction as GalNAc4S-Ido (Fig. 1 ). We were unable to detect uronic acid (Hopwood & Elliott, 1981a) 
The specific radioactivities of the radiolabelled substrates GalNAc4S and GalNAc4S-Ido were approx. 2 and 450 Ci/mol of hexosamine (Hopwood & Elliott, 1985) respectively. The penta-and tri-saccharide substrates derived from chondroitin 4-sulphate all had a specific radioactivity of 90 Ci/mol.
Enzyme preparation
Fibroblast cultures were established from skin biopsies taken in or provided to this hospital . Patients classified as having MPS VI excreted excessive amounts of dermatan sulphate in their urine , had normal activities of other mucopolysaccharidosis enzymes and were deficient in aryl B activity when cultured fibroblasts were assayed with GalNAc4S-GlcA-GalitolNAc4S or after electrophoretic separation of arylsulphatase isoenzymes by the Vol. 234 method described by Ratazzi et al. (1973) . Typing ofother mucopolysaccharidosis patients was based on the extent and type of glycosaminoglycanuria, clinical phenotype and nature of lysosomal-enzyme deficiency .
Cultured amnioticcells and peripheral-blood leucocytes were isolated as previously described (Carey & Pollard, 1977) . All cells were suspended in aqueous Triton X-100 (1 g/l) to a concentration of 5-10 g of protein/l and were disrupted by rapid freezing and thawing six times in a solid-CO2/ethanol mixture.
Enzyme assays
Incubation mixtures contained 8-15 jg of protein from cultured fibroblast homogenates in 50 mM-sodium formate buffer, pH 4.0, containing 4 mM-NaN3, fl-N-Acetylhexosaminidase inhibitor*... Table 2 . Km and V values for aryl B activity in cultured-skin-fibroblast homogenates towards oligosaccharides and a monosaccharide substrate
All incubations were at pH 4.0 in 50 mM-sodium acetate buffer containing fl-N-acetylhexosaminidase inhibitor (5 mM).
5 mM-D-saccharic acid 1,4-lactone and approx. 500 pmol of substrate in a final volume of 20,1 in a sealed polypropylene tube (Hopwood & Elliott, 198 la 
RESULTS
Fibroblast aryl B activity was measured at pH 4.0 with the substrates shown in Fig. 1 . Desulphation of these substrates by aryl B yields unlabelled sulphate (except for GalNAc4S) and the corresponding tritiated oligosaccharide with decreased mobility on high-voltage electrophoresis. Hydrolysis of GalNAc4S-GlcA-GalitolNAc4S produced three products (Fig. 2) . Product 1 results from the action of aryl B. Product 2 results from the action of ,-N-acetylhexosaminidase either directly on the ,/-glycosidic linkage of the GalNAc4S residue or on the GalNAc residue in the product of aryl B activity (Scheme 1). We have previously shown that the addition of ,-N-acetylhexosaminidase inhibitor (2-acetoamido-2-deoxy-D-gluconolactone) and incubation in 50 mMsodium acetate buffer, pH 4.0, results in the complete inhibition of ,J-N-acetylhexosaminidase activity towards these types of substrates (Hopwood & Elliott, 1983 . Further degradation of 8-N-acetylhexosaminidase Product 2 (i.e. GlcA-GalitolNAc4S) to Product 3 (i.e. N-acetylgalactosaminitol-sulphate 4) was inhibited by the addition (5 mM) of the fi-glucuronidase inhibitors D-saccharic acid 1 ,4-lactone to these incubation mixtures (Scheme 1 and Fig. 2) . Results recorded in Table 1 suggest that GalNAc4S-GlcA-GalNAc4S-GlcA-GalitolNAc4S, GalNAc4S-GlcA-GalitolNAc4S and GalNAc4S-GlcGalitolNAc4S are desulphated by the same enzyme at a considerably higher rate than observed for GalNAc4S-Ido and GalNAc4S. MPS-VI-fibroblast homogenates incubated in the presence ofan inhibitor of,-N-acetylhexosaminidase with all substrates except the pentasaccharide were unable to produce detectable aryl B activity. In the absence of fl-N-acetylhexosaminidase inhibitor, small amounts of Product 2 were produced from incubations of MPS-VI-fibroblast homogenates containing GalNAc4S-GlcA-GalitolNAc4S and GalNAc4S-Glc-GalitolNAc4S. Although the amount of hydrolysis was low, it appeared that the amounts ofproduct from incubations of GalNAc4S-Ido with normal and MPS-VI-fibroblast homogenates were significantly decreased when incubation mixtures contained the fl-N-acetylhexosaminidase inhibitor. The monosaccharide GalNAc6S was desulph ted after incubation with MPS-VI-fibroblast or normalfibroblast homogenates. Hydrolysis of GalNAc6S was not detected in incubations with MPS-IVA (N-acetylgalactosamine 6-sulphate sulphatase-deficient)-fibroblast homogenates.
Apparent Km and V values measured in normalfibroblast homogenates and recorded in Table 2 were obtained from Lineweaver-Burk plots. Some comparison ofbinding and catalysis ofvarious substrates can be made from the data. Desulphation of GalitolNAc4S by fibroblast homogenates was not detected. The most effective substrate with the highest V value was the pentasaccharide. However, as separation of products from substrate was difficult and high residual activity in MPS-VI-fibroblast homogenates was obtained, the trisaccharide GalNAc4S-GlcA-GalitolNAc4S was evaluated as a diagnostic substrate for the detection of MPS-VI patients. The effect of incubation pH on fibroblast hydrolysis of GalNAc4S-GlcA-GalitolNAc4S is complex and is recorded in Fig. 3 . The pH optimum of aryl B activity was 3.5-4.0 in formate buffer. Hydrolysis of the trisaccharide substrate in formate buffer produced two products at pH 4.0, but virtually only one at pH 3.5. Incubation in acetate buffer at pH 4.0 caused almost complete inhibition of,3-N-acetylhexosaminidase activity towards this substrate and diminished the overall aryl B activity at this incubation pH. It was possible to decrease /?-N-acetylhexosaminidase activity to very low values without a large decrease in aryl B activity by incubation of the trisaccharide substrate in sodium formate buffer, pH 3.5 (Fig. 3) . Aryl B activity in normal-fibroblast homogenates increased linearly with time up to 24 h at 37°C at low protein concentrations (approx. 5 tg total in an incubation volume of 20 1,), as shown by the linear increase in Product 1 as well as Product 2 (Fig. 4) . Activity was not linear with protein over the concentration range studied, mainly owing to the non-linearity with time of the formation of Product 1 (Fig. 5) . Incubations at 45°C gave higher aryl B activities than were observed at 37°C, but the conversion into product was not linear with time (Fig. 4) . Dialysis of fibroblast homogenates against 50 mM-sodium formate buffer, pH 4.0, for 16 h at 4°C resulted in an up to 2-fold increase in aryl B activity. Sulphatase activity in cell homogenates measured with GalNAc4S-GlcA-GalitolNAc4S was slightly stimulated by the addition of NaCl up to 20 mM. At higher NaCl concentrations enzyme activity was inhibited (Fig. 6) . Enzyme activity was inhibited by 40% and 50% by 1 mM-Na2SO4 and -phosphate respectively. term and pregnancy 2 was terminated. All prenatal assessments were confirmed on follow-up samples ofcord blood, urine or skin fibroblasts from pregnancies 1 and 3-5 and cultured skin fibroblasts from the abortus of pregnancy 2. DISCUSSION A major conclusion from the kinetic data (Table 2) is that the aglycone structure attached to GalNAc4S considerably influences the catalytic efficiency offibroblast homogenate aryl B. The observed V value increases with increasing chain length of substrate, and this is consistent with the results reported by Habuchi et al. (1979) for rat skin aryl B. The GalNAc4S residue in the pentasaccharide was desulphated more than 4000-fold faster than was the monosaccharide GalNAc4S.
Similar findings have been reported for the different sulphatase (N-acetylgalactosamine 6-sulphate sulphatase) involved in the desulphation of oligosaccharides and a monosaccharide derived from chondroitin 6-sulphate (Elliott & Hopwood, 1984; Hopwood & Elliott, 1985) . The non-reducing end sulphate ester in GalNAc6S-GlcAGalitolNAc6S was hydrolysed approx. 1000-fold faster than was the monosaccharide GalNAc6S.
The presence ofan adjacent-residue C-6 carboxy group and a sulphate ester group two residues removed from the (Hopwood & Elliott, 1981b; Freeman & Hopwood, 1986 (Hopwood & Elliott, 198 la, 1982 Elliott & Hopwood, 1984 (Fluharty, 1981) .
There are two major problems associated with using GalNAc4S substrates to measure residual aryl B activity that may be present in MPS-VI patients. Under the conditions used to assess aryl B activity towards GalNAc4S-GlcA-GalitolNAc4S, N-acetylgalactosamine 6-sulphate sulphatase activity (which is normal in MPS-VI fibroblasts) is 10-fold more efficient at desulphation of GalNAc6S-GlcA-GalitolNAc6S. Thus small amounts of non-reducing-end GalNAc6S residues in the diagnostic substrate would be completely desulphated under the extended conditions used to detect residual aryl B. We suspect that the differences in aryl B activity observed in fibroblasts from the propositus in family A as determined in assessments 1 and 2 (Table 4) may have resulted from the presence of trace amounts of GalNAc6S residues in the substrate preparation used in assessment 2. A second source of apparent residual activity may result from the action of f,-N-acetylhexosaminidase on the ,-glucosidic bond of the GalNAc4S residue to yield the radiolabelled GlcA-GalitolNAc4S. This product may mistakenly be considered to have resulted from the sequential action of aryl B and,8-N-acetylhexosaminidase activities (Hopwood & Elliot, 1985) . Any apparent contribution to residual aryl B activity via this pathway is probably eliminated by incubation under conditions that inhibit ,f-N-acetylhexosaminidase activity towards these substrates (Table 1 ; Hopwood & Elliott, 1985) .
We conclude that, under the conditions defined in the study, radiolabelled GalNAc4S-GlcA-GalitolNAc4S isolated from chondroitin 4-sulphate is an effective and highly specific substrate for aryl B and may be used to diagnose MPS VI. Care to remove small amounts of Vol. 234 trisaccharides containing GalNAc6S residues from substratepreparationsandchoiceofincubationconditions to inhibit ,-N-acetylhexosaminidase activity make GalNAc4S-GlcA-GalitolNAc4S an important substrate for the prenatal and postnatal detection ofaryl B deficiencies. Further work is required to investigate the possibility that some MPS-VI clinical variants may produce significant, but very low, residual activity with the trisaccharide substrate and thereby provide a means of biochemical classification ofdifferent MPS-VI phenotypes, as we have already reported for a group of MPS-I patients (Hopwood & Muller, 1979; Muller & Hopwood, 1984 
